Morgan Stanley Maintains Equal-Weight on Exelon, Raises Price Target to $41
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst David Arcaro maintains an Equal-Weight rating on Exelon (NASDAQ:EXC) and raises the price target from $38 to $41.
May 28, 2024 | 5:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley analyst David Arcaro maintains an Equal-Weight rating on Exelon and raises the price target from $38 to $41.
The raised price target from $38 to $41 by a reputable analyst at Morgan Stanley is likely to have a positive short-term impact on Exelon's stock price, as it reflects increased confidence in the company's valuation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100